Supplementary Table 2 from Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
Chantal Pauli(University of Zurich), Mark A. Rubin(University of Bern), Reid Shaw(Precision for Medicine (United States)), Terra J. McNary(Cornell University), Bishoy M. Faltas(Cornell University), Juan Miguel Mosquera(NewYork–Presbyterian Hospital), Andrea Sboner(Cornell University), Himisha Beltran(Dana-Farber Cancer Institute), Tarcisio Fedrizzi(University of Trento), Yelena Churakova(Cornell University), Lewis C. Cantley(Harvard University), Loredana Puca(Eli Lilly (United States)), Olivier Elemento(Cornell University), Benjamin D. Hopkins(Cornell University), Brian Robinson, Francesca Demichelis(University of Trento), Carla Grandori(Precision for Medicine (United States)), Vijayakrishna K. Gadi(Fred Hutch Cancer Center), Michael A. Augello(Cornell University), Rachele Rosati(Precision for Medicine (United States)), Brady Bernard(Providence Portland Medical Center), Rema Rao(Cleveland Clinic), David J. Pisapia(NewYork–Presbyterian Hospital), Brooke E. Emerling(Cornell University), Verena Sailer(Cornell University), Cynthia Cheung(Cornell University), Davide Prandi(University of Trento), Christopher J. Kemp(Fred Hutch Cancer Center), Joanna Triscott(BC Children's Hospital)
Cited by 0
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k